Año:
2022
CiteScore:
3,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cell Biology | 222/274 | Q4 | T3 | D9 |
SJR año:
2023
Factor de Impacto:
0,133
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cell Biology | 281/295 | Q4 | T3 | D10 |
Agencia | Código de Proyecto |
---|---|
Dept. of Radiation Oncology at Weill Cornell Medicine (New York, US) | - |
Functional Genomics Initiative (New York, US) | - |
Leukemia and Lymphoma Society (LLS) | - |
Lytix Biopharma (Oslo, Norway) | - |
Promontory (New York, US) | - |
Stand Up to Cancer (SU2C) | ZP-6177 |
US DoD BRCP | BC180476P1; BC210945 |
# | Autor | Afiliación |
---|---|---|
1 | Álvarez-Abril, Beatriz | Weill Cornell Medicine; Hospital Morales Meseguer (United States) |
2 | Bloy, Norma | Weill Cornell Medicine (United States) |
3 | Galassi, Claudia | Weill Cornell Medicine (United States) |
4 | Sato, Ai | Weill Cornell Medicine (United States) |
5 | Jiménez-Cortegana, Carlos | Weill Cornell Medicine (United States) |
6 | Klapp, Vanessa | Weill Cornell Medicine (United States) |
7 | Aretz, Artur | Weill Cornell Medicine (United States) |
8 | Guilbaud, Emma | Weill Cornell Medicine (United States) |
9 | Buqué, Aitziber | Weill Cornell Medicine (United States) |
10 | Weill Cornell Medicine; Caryl and Israel Englander Institute for Precision Medicine (United States) | |
11 | Weill Cornell Medicine (United States) |